Marisa Karow

Marisa Karow

Auto-generated profile, based on publicly available information

Marisa Karow

Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2007 in Blood
Verified
Journal Article
Open access
PDF file
CRChristian Ries
Christian Ries
VEVirginia Egea
Virginia Egea
MKMarisa Karow
Marisa Karow
HKHelmut Kolb
Helmut Kolb
MJMarianne Jochum
Marianne Jochum
PNPeter Neth
Peter Neth
Human mesenchymal stem cells (hMSCs) represent promising tools in various clinical applications, including the regeneration of injured tissues by endogenous or transplanted hMSCs. The molecular mechanisms, however, that control hMSC mobilization and homing which require invasion through extracellular matrix (ECM) barriers are almost unknown. We have analyzed bone marrow–derivedhMSCs and detected strong expression and synthesis of matrix metalloproteinase 2 (MMP-2), membrane type 1 MMP (MT1-MMP), tissue inhibitor of metalloproteinase 1 (TIMP-1), and TIMP-2. The ability of hMSCs to traverse reconstituted human basement membranes was effectively blocked in the presence of synthetic MMP inhibitors. Detailed studies by RNA interference revealed that gene knock-down of MMP-2, MT1-MMP, or TIMP-2 substantially impaired hMSC invasion, whereas silencing of TIMP-1 enhanced cell migration, indicating opposing roles of both TIMPs in this process. Moreover, the inflammatory cytokines TGF-β1, IL-1β, and TNF-α up-regulated MMP-2, MT1-MMP, and/or MMP-9 production in these cells, resulting in a strong stimulation of chemotactic migration through ECM, whereas the chemokine SDF-1α exhibited minor effects on MMP/TIMP expression and cell invasion. Thus, induction of specific MMP activity in hMSCs by inflammatory cytokines promotes directed cell migration across reconstituted basement membranes in vitro providing a potential mechanism in hMSC recruitment and extravasation into injured tissues in vivo.

1 March 2016 in Cell Stem Cell
Verified
Journal Article
Closed access
SGSergio Gascón
Sergio Gascón
Elisa MurenuElisa Murenu
Elisa Murenu
GMGiacomo Masserdotti
Giacomo Masserdotti
Felipe OrtegaFelipe Ortega
Felipe Ortega
GRGianluca L. Russo
Gianluca L. Russo
MGMagdalena Götz
Magdalena Götz

1 October 2012 in Cell Stem Cell
Verified
Journal Article
Closed access
MKMarisa Karow
Marisa Karow
RSRodrigo Sánchez
Rodrigo Sánchez
CSChristian Schichor
Christian Schichor
GMGiacomo Masserdotti
Giacomo Masserdotti
Felipe OrtegaFelipe Ortega
Felipe Ortega
BBBenedikt Berninger
Benedikt Berninger

18 June 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
MKMarisa Karow
Marisa Karow
JCJ. Gray Camp
J. Gray Camp
SFSven Falk
Sven Falk
TGTobias Gerber
Tobias Gerber
APAbhijeet Pataskar
Abhijeet Pataskar
BBBenedikt Berninger
Benedikt Berninger

9 April 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
ÁHÁlvaro Herrero-Navarro
Álvaro Herrero-Navarro
LPLorenzo Puche-Aroca
Lorenzo Puche-Aroca
VMVerónica Moreno-Juan
Verónica Moreno-Juan
ASAlejandro Sempere-Ferràndez
Alejandro Sempere-Ferràndez
AEAna Espinosa
Ana Espinosa
GLGuillermina López-Bendito
Guillermina López-Bendito
Region-specific gene expression shared with neurons imparts to astrocytes competence for region-specific neuronal reprogramming.

Verified
Journal Article
Open access
PDF file
CGClaudia Günther
Claudia Günther
VRVeit Rothhammer
Veit Rothhammer
MKMarisa Karow
Marisa Karow
MNMarkus F Neurath
Markus F Neurath
BWBeate Winner
Beate Winner
The gut–brain axis is a bidirectional communication system driven by neural, hormonal, metabolic, immunological, and microbial signals. Signaling events from the gut can modulate brain function and recent evidence suggests that the gut–brain axis may play a pivotal role in linking gastrointestinal and neurological diseases. Accordingly, accumulating evidence has suggested a link between inflammatory bowel diseases (IBDs) and neurodegenerative, as well as neuroinflammatory diseases. In this context, clinical, epidemiological and experimental data have demonstrated that IBD predisposes a person to pathologies of the central nervous system (CNS). Likewise, a number of neurological disorders are associated with changes in the intestinal environment, which are indicative for disease-mediated gut–brain inter-organ communication. Although this axis was identified more than 20 years ago, the sequence of events and underlying molecular mechanisms are poorly defined. The emergence of precision medicine has uncovered the need to take into account non-intestinal symptoms in the context of IBD that could offer the opportunity to tailor therapies to individual patients. The aim of this review is to highlight recent findings supporting the clinical and biological link between the gut and brain, as well as its clinical significance for IBD as well as neurodegeneration and neuroinflammation. Finally, we focus on novel human-specific preclinical models that will help uncover disease mechanisms to better understand and modulate the function of this complex system.